Contrary to the narrative of government inefficiency, Medicare's administrative overhead is only 2%. In contrast, private commercial insurers spend 16% of every dollar on administration, advertising, and claim disputes, revealing a major source of bloat in the US healthcare system.

The US government, as the dominant healthcare buyer through Medicare and Medicaid, has immense potential "monopsony" power to control prices. The central political conflict in healthcare will be how aggressively the public sector uses this leverage to squeeze providers and drug makers, balancing cost control against innovation incentives.

A significant hidden cost in the US healthcare system is the administrative expense of price negotiation. For a well-run hospital, the process of billing, negotiating, and receiving reimbursement from insurance companies can consume 2% to 7% of a patient's total bill, adding a substantial layer of inefficiency.

The US healthcare market suffers because massive, consolidated hospital systems and payers create negotiating "loggerheads." With no viable alternatives, they reach inefficient agreements where costs are inflated for everyone. A more fragmented market with smaller players would foster more genuine and effective price competition.

Imposing bureaucratic hurdles to reduce consumption of medical procedures, like knee surgery, is an unfair method of rationing care. It allocates resources based on a patient's ability to navigate paperwork rather than on medical need. More legitimate policy levers include price controls or adjusting provider payment rates.

As the US population ages, more people enroll in Medicare, which typically under-reimburses hospitals for the full cost of care. To compensate for this revenue shortfall, hospitals raise the prices for patients with private, employer-sponsored insurance, effectively shifting costs from the public plan to commercial payers.

Official healthcare inflation appears lower than reality because hospitals are currently absorbing rising costs by accepting lower profit margins. This is not sustainable and suggests future price hikes as hospitals pass these costs on to insurers in upcoming negotiation cycles, which occur every two to three years.

The immense regulatory complexity in U.S. healthcare creates an estimated $500 billion "tax" of administrative bloat. The non-obvious opportunity is that by using AI to eliminate this waste, the savings could be redirected to fund expanded patient care, rather than just being captured as profit.

High healthcare costs are not an inherent failure of capitalism but a result of regulatory capture. Established companies influence legislation to create immense barriers to entry, stifling innovation from new competitors, which leads to ballooning administrative costs instead of more physicians and better care.